Ardynn PSDM Support
Personalized Shared Decision-Making (PSDM) Support brings clarity to first-course cancer treatment decisions. It pairs non-clinical advocacy with real-world outcomes analytics, summarized in a structured, patient-friendly report to inform goal-concordant treatment planning.
for stakeholders committed to patient centered, value‑based healthcare
Oncology decision-making without personalized, real-world outcomes is incomplete and exposes patients and payors to avoidable risk.
Without real-world context, it is difficult to demonstrate that treatment decisions were fully informed, goal-concordant, or aligned with what matters most to the patient.
Ardynn PSDM Support pairs compassionate advocacy with our proprietary real‑world data platform, Capire360. This combination ensures treatment choices are informed, personalized and aligned with what matters most to the patient, organically reducing the likelihood of low‑value or misaligned decisions.
Decision Support delivered by advocates — Powered by Capire360
Capire360 analyzes millions of real-world cancer cases to show how people with similar characteristics — age, sex, race, comorbidities, cancer type, and stage — experienced different treatment paths. Reflecting real populations rather than narrow clinical‑trial cohorts, Capire360 provides a grounded view of outcomes. It informs decisions without dictating them. Our advocates translate these data into clear, understandable insights so individuals can weigh trade‑offs, quality‑of‑life impacts and realistic options.
improved decision quality.
A win-win-win.
For Individuals & Families
- Clarity and confidence grounded in real-world outcomes
- Decisions aligned with personal values
- Less emotional overwhelm
- Reduced decisional conflict and regret
- Better day-to-day experience during treatment
For Providers
- Strengthened shared decision-making
- Better-prepared individuals
- Reduced non-clinical burden
- Stronger communication and understanding
- Compliance-ready documentation
For Health Plans & Payviders
- Lower utilization of low-value or misaligned treatments
- Earlier engagement and fewer complications
- A non-clinical benefit aligned with plan priorities
- Improved CAHPS and STAR experience metrics
- Support for goal-concordant, value-based oncology care
Ardynn Advocates:
The Human centerpiece
Ardynn advocates engage early to bring structure, empathy, and clarity to a complex moment. They provide:
- Early rapport-building during or near the diagnostic phase
- Inclusion of family members when desired
- Compassionate exploration of goals, fears, values, and priorities
- Translation of real-world outcome insights into plain language
- Structured preparation for oncology appointments
- Non-clinical support throughout active treatment
- Education on supportive and palliative care when appropriate
- HIPAA-compliant communication and documentation
Every patient receives a Personalized Shared Decision-Making Report documenting personal goals alongside Capire360 insights, creating a clear, consistent foundation for shared decision-making and value-based care discussions. This approach ensures individuals feel seen, heard, supported, and prepared for meaningful shared decision-making. This approach ensures individuals feel seen, heard, supported, and prepared for meaningful shared decision-making, and the report itself serves as audit-ready documentation that supports quality initiatives.
Most individuals we work with find that clarifying their goals and preferences helps them select a guideline-supported treatment approach that feels truly aligned with what matters to them. When individuals prioritize quality of life, they often opt out of low-value treatments, and in doing so, reduce downstream utilization, and avoidable second opinions—without duplicating clinical services.
Member story
"Seeing Ardynn's proprietary outcomes data for people like me with the same type of cancer - and having my advocate share insights about it - was a game changer. It helped me make confident treatment decisions and gave me peace of mind."
Steve is just one of the many members we have helped with personalized, compassionate care that supported and empowered him to make informed decisions about his treatment. Want to learn more about Steve’s journey and those of other Ardynn members?
The Ideal Pathway
Shared decision-making works best when oncologists refer individuals to Ardynn at the beginning of the diagnostic process.
Early engagement ensures:
- PSDM Support has maximum impact on treatment decisions
- Trusted, non-clinical guidance complements—not complicates—the oncology care plan
- More focused, values-aligned shared decision-making conversations
- Reduced non-clinical burden for oncology teams
- Stronger comprehension, preparation, and trust among individuals and families
An oncologist referral reinforces Ardynn as a partner in care—not a duplicative service—supporting a more coordinated, person-centered experience.
Have questions?
Get in touch
Visit
901 S Mopac Expy
Bldg. 1, Ste. 300
Austin, TX 78746
Call
(512) 708 9000
info@potentiametrics.com